Literature DB >> 33664273

A cryptic splice-altering KCNQ1 variant in trans with R259L leading to Jervell and Lange-Nielsen syndrome.

Mario Torrado1, Germán Fernández2, Christian A Ganoza2, Emilia Maneiro2, Diego García2, Natalia Sonicheva-Paterson2, Isaac Rosa2, Juan Pablo Ochoa2, Luis Santomé2, Elena Vasichkina3, Lorenzo Monserrat2.   

Abstract

Here we report an infant with clinical findings suggestive of Jervell and Lange-Nielsen syndrome (JLNS), including a prolonged QT interval (LQTS) and chronic bilateral sensorineural deafness. NGS analysis revealed one known heterozygous pathogenic missense variant, KCNQ1 p.R259L, previously associated with LQTS but insufficient to explain the cardioauditory disorder. In a screening of proximal intronic regions, we found a heterozygous variant, KCNQ1 c.1686-9 T > C, absent from controls and previously undescribed. Several splicing prediction tools returned low scores for this intronic variant. Driven by the proband's phenotype rather than the neutral predictions, we have characterized this rare intronic variant. Family analysis has shown that the proband inherited the missense and the intronic variants from his mother and father, respectively. A minigene splicing assay revealed that the intronic variant induced an additional transcript, arising from skipping of exon 14, which was translated into a truncated protein in transfected cells. The splice-out of exon 14 creates a frameshift in exon 15 and a stop codon in exon 16, which is the last exon of KCNQ1. This mis-spliced transcript is expected to escape nonsense-mediated decay and predicted to encode a truncated loss-of-function protein, KCNQ1 p.L563Kfs*73. The analysis of endogenous KCNQ1 expression in the blood of the proband's parents detected the aberrant transcript only in the patient's father. Taken together, these analyses confirmed the proband's diagnosis of JLNS1 and indicated that c.1686-9 T > C is a cryptic splice-altering variant, expanding the known genetic spectrum of biallelic KCNQ1 variant combinations leading to JLNS1.

Entities:  

Year:  2021        PMID: 33664273      PMCID: PMC7933243          DOI: 10.1038/s41525-021-00183-y

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN: 2056-7944            Impact factor:   8.617


  31 in total

1.  An elderly Jervell and Lange-Nielsen patient heterozygous compound for two new KCNQ1 mutations.

Authors:  Eliecer Coto; Francisco J García-Fernández; David Calvo; Ricardo Salgado-Aranda; Javier Martín-González; Belén Alonso; Sara Iglesias; Juan Gómez
Journal:  Am J Med Genet A       Date:  2016-11-21       Impact factor: 2.802

2.  Mutational and phenotypic spectra of KCNE1 deficiency in Jervell and Lange-Nielsen Syndrome and Romano-Ward Syndrome.

Authors:  Rabia Faridi; Risa Tona; Alessandra Brofferio; Michael Hoa; Rafal Olszewski; Isabelle Schrauwen; Muhammad Z K Assir; Akhtar A Bandesha; Asma A Khan; Atteeq U Rehman; Carmen Brewer; Wasim Ahmed; Suzanne M Leal; Sheikh Riazuddin; Steven E Boyden; Thomas B Friedman
Journal:  Hum Mutat       Date:  2018-12-12       Impact factor: 4.878

Review 3.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Transl Res       Date:  2012-09-17       Impact factor: 7.012

4.  Variant Review with the Integrative Genomics Viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Aaron M Wenger; Ahmet Zehir; Jill P Mesirov
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

5.  Mutations in the hminK gene cause long QT syndrome and suppress IKs function.

Authors:  I Splawski; M Tristani-Firouzi; M H Lehmann; M C Sanguinetti; M T Keating
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

6.  Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.

Authors:  Annika Winbo; Inger Fosdal; Maria Lindh; Ulla-Britt Diamant; Johan Persson; Göran Wettrell; Annika Rydberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-05-27

7.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

8.  Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening.

Authors:  Mark A Zaydman; Jonathan R Silva; Kelli Delaloye; Yang Li; Hongwu Liang; H Peter Larsson; Jingyi Shi; Jianmin Cui
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-16       Impact factor: 11.205

9.  Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.

Authors:  Rune Frank-Hansen; Stephen P Page; Petros Syrris; William J McKenna; Michael Christiansen; Paal Skytt Andersen
Journal:  Eur J Hum Genet       Date:  2008-03-12       Impact factor: 4.246

10.  An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome.

Authors:  Zahurul A Bhuiyan; Tarek S Momenah; Ahmad S Amin; Ayman S Al-Khadra; Marielle Alders; Arthur A M Wilde; Marcel M A M Mannens
Journal:  Prog Biophys Mol Biol       Date:  2008-11-05       Impact factor: 3.667

View more
  2 in total

1.  Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree.

Authors:  Mario Torrado; Emilia Maneiro; Arsonval Lamounier Junior; Miguel Fernández-Burriel; Sara Sánchez Giralt; Ana Martínez-Carapeto; Laura Cazón; Elisa Santiago; Juan Pablo Ochoa; William J McKenna; Luis Santomé; Lorenzo Monserrat
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

2.  KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation.

Authors:  Yuanxiu Song; Tianwei Guo; Youxu Jiang; Min Zhu; Hongyue Wang; Wenjing Lu; Mengqi Jiang; Man Qi; Feng Lan; Ming Cui
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.